Schedule 13D ownership disclosure

BEONE MEDICINES LTD SPONSORED ADS

Ordinary shares, par value $0.0001 per share · CUSIP: 07725L102

Event date: 2025-05-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • HHLR Advisors, Ltd.Reported CIK 0001762304

    Shares: 68,551,141.00 · Class: 4.9%

  • Hillhouse Investment Management, Ltd.Reported CIK 0001510589

    Shares: 68,551,141.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002297
Form type
SCHEDULE 13D/A
Filer
BeOne Medicines Ltd.
CIK
CIK 1651308
Filed
May 13, 2025
Reporting period
May 09, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub